Shingrix zoster vaccine is newly added to the market and approved by US FDA and EU EMA. Shingrix is more than 90% effective at preventing shingles and post-herpetic neuralgia. People who aged 50 or above and aged 18 or above high-risk individuals should receive two doses of this vaccine(with each dose administered 2-6 months apart). Side effects are temporary, including sore arm with mild or moderate pain, redness and swelling at injection site, tiredness, muscle pain, a headache, shivering, fever, stomach pain, or nausea. Symptoms went away on their own in about 2 to 3 days. You should not get Shingrix if you have severe allergic rection to any component of the vaccine of the previous dose, currently have shingles or currently are pregnant or breastfeeding.